­

June 2016

New publication in the prestige “Journal of Arthroplasty” demonstrates that Using an IPCD and TXA and discontinuing enoxaparin and preoperative autologous blood donation eliminated blood transfusion in primary THA and TKA without any increase in VTED. Using an IPCD instead of enoxaparin, adding TXA, and eliminating preoperative autologous donation each had an incremental dose response [...]

June 2016

Activecare® gets additional evidence for its efficiency: New publication in the prestige “Journal of Arthroplasty” Confirming Patient Satisfaction, Safety, Efficacy and Reduction of Hospital Readmissions with ActiveCare® DVT prophylaxis Mobile Compression Device Following Joint Replacement Surgery. This was a prospective study of 3,143 patients undergoing primary or revision knee or hip arthroplasty. Study title: The Effectiveness [...]

November 2015

Following the study presented at the American Association of Hip and Knee Surgeons 25th Annual Meeting that shows ActiveCare® Mobile Compression DVT Prophylaxis Following Total Joint Replacement Surgery Leads To Significant Hospitals Cost Reductions. M.D Richard Iorio talks study on VTE and synchronized mobile compression Watch video

November 2015

Medical Compression Systems Additional good news for #ORTHOPEDIC SURGEONS AND #HOSPITAL ADMINISTRATION: New Study Shows ActiveCare® Mobile Compression DVT Prophylaxis Following Total Joint Replacement Surgery Leads To SIGNIFICANT HOSPITALS COST REDUCTIONS link text

April 2015

Just released: New data further validating the use of the ActiveCare® DVT prophylaxis compression system following total joint replacement procedures. This study, selected as the best poster in the adult reconstruction category, was presented at the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting. You are welcome to read more about it here

March 2015

ActiveCare took part at AAOS 2015 - American Academy of Orthopaedic Surgeons, that took place in Las Vegas, March 25-27. Many TJR surgeons gathered around our booth, learning how to prevent VTE in TJA patients with no major bleeding reported. Visitors at our booth participated in a survey dedicated to learn how TJR surgeons confront the risks of [...]

December 2014

ActiveCare® in CCJR 2014: Just Say No to Drugs" ActiveCare® participated in CCJR 2014, Current Concepts in Joint Replacement, held in Florida, Dec 10-14. During this conference, leading orthopedic surgeon Robert L. Barrack, M.D., Chief of Orthopedics at Barnes Jewish Hospital and professor at Washington University School of Medicine in St. Louis, MO, gave a [...]

June 2014

ActiveCare® at EFORT 2014 Congress in London Over 7000 colleagues attended the Annual Congress of The European Federation of National Associations of Orthopaedics and Traumatology (EFORT). ActiveCare® attracted the attention of many orthopedic surgeons seeking new and safer solutions for DVT prevention. Physicians from the UK, Denmark, Sweden, Japan, Australia, Malaysia, Italy, Spain, Romania and more visited our booth [...]

March 2014

ActiveCare® received an incredible push forward by leading orthopedic surgeons during AAOS American Academy of Orthopaedic Surgeons 2014, the largest academic conference on orthopedic surgery, which was held in March in New Orleans. It was a great opportunity for ActiveCare® to leverage the recognition received  after our clinical research was published in the The Journal of Bone [...]

February 2014

Activecare® gets professional recognition: Research on the device is published as a leading article in the most prestige journal JBJS. A special commentary is dedicated to this research in the Feb edition.  First Ever Large Scale Orthopedic Study Published in JBJS as Leading Article Approves the Change in How Patients are Treated to Prevent Deep Vein [...]

December 2013

When an Israeli company nears the sales stage, the debate whether it is time to hire an American CEO almost always begins. A man who knows the target market, has more experience in sales (very few Israeli managers of life sciences companies have reached this stage), and who can open doors. A well-known American CEO [...]

October 2013

Dr. Robert Barrack in the Charnley Lecture at 2013 BOA Annual Congress: “It is the First Time That the US Deep Vein Thrombosis (DVT) Prevention Guidelines Have Been Modified for the Interest of the Orthopedic Surgeons.”